Does the gastrointestinal microbiome contribute to the 'obesity paradox' in melanoma survival?

Br J Dermatol. 2018 Jul;179(1):225-226. doi: 10.1111/bjd.16681. Epub 2018 May 13.

Authors

E A Langan^{1

2}, V Grätz¹, F Billmann³, D Zillikens¹, P Terheyden¹

Affiliations

¹ Department of Dermatology, University of Lübeck, Lübeck, Germany.
² Centre for Dermatological Science, University of Manchester, Manchester, U.K.
³ Department of Surgery, University Clinic of Heidelberg, Heidelberg, Germany.

PMID: 29663324
DOI: 10.1111/bjd.16681

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / therapeutic use*
Female
Gastrointestinal Microbiome / immunology*
Host Microbial Interactions / immunology
Humans
Male
Melanoma / drug therapy*
Melanoma / immunology
Melanoma / mortality
Melanoma / pathology
Obesity / complications
Obesity / immunology*
Obesity / microbiology
Progression-Free Survival
Sex Factors
Skin / immunology
Skin / pathology
Skin Neoplasms / drug therapy*
Skin Neoplasms / immunology
Skin Neoplasms / mortality
Skin Neoplasms / pathology
Survival Analysis
Tumor Microenvironment / drug effects
Tumor Microenvironment / immunology

Substances

Antineoplastic Agents